Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

NovAliX and Chemical.AI announce drug discovery collaboration

January 25, 2021 Sales and Marketing Chemical.AI, Novalix

NovAliX, a drug discovery-focused contract research organisation, and Chemical.AI, an artificial intelligence (AI) company, have announced a strategic collaboration in …
News

FDA approves Exelixis’ cancer drug Cabometyx

January 25, 2021 Sales and Marketing Cancer, Exelixis

The FDA has approved Exelixis’ Cabometyx (cabozantinib) for patients with advanced renal cell carcinoma (RCC) as a first-line treatment in …
News

New study challenges link between stress and migraines

January 25, 2021 Sales and Marketing Curelator, migraine

Digital health platform Curelator has announced new data that shows a lack of association between increased stress and migraine attacks. …
News

Genentech announces positive top-line results for “wet” age-related macular degeneration antibody

January 25, 2021 Sales and Marketing Genentech

Genentech has announced positive top-line results from two identically designed global Phase III studies, TENAYA and LUCERNE, evaluating its investigational …
News

Merck KGaA’s cancer drug Bavencio gets EU approval

January 25, 2021 Sales and Marketing Merck KGaA

The EC has approved Merck KGaA’s BAVENCIO (avelumab) as monotherapy for the first-line maintenance treatment of adult patients with locally …
News

Raremark appoints Nicki Grundy as CFO

January 20, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark, a global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer. As a key …
Appointment

Jubilant and The Wistar Insitute collaborate on potential COVID-19 treatment

January 18, 2021 Sales and Marketing Jubilant Therapeutics

Jubilant Therapeutics, a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, has …
News

Theramex launches osteoporosis drug Livogiva in Europe

January 18, 2021 Sales and Marketing Theramex, osteoporosis

Theramex, a London-headquartered pharmaceutical company dedicated to women’s health, has launched osteoporosis medicine Livogiva to patients in Europe for the …
News

ViiV and Chelsea & Westminster Hospital launch digital service for HIV patients

January 18, 2021 Sales and Marketing HIV, ViiV Healthcare

Global specialist HIV company ViiV Healthcare and Chelsea and Westminster Hospital NHS Foundation Trust have launched a new service, Klick, …
News

US Department of Defense selects Faron for $6.1m COVID-19 research funding

January 18, 2021 Sales and Marketing Faron Pharmaceuticals, US

The US Department of Defense (DoD) has selected Faron Pharmaceuticals’ HIBISCUS study to receive $6.1 million of funding from the …
News

FDA approves Janssen’s AL amyloidosis drug

January 18, 2021 Sales and Marketing FDA, Janssen

The FDA has approved Janssen’s DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone …
News

Purespring Therapeutics to appoint Richard Francis as CEO

January 11, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from …
Appointment

Eli Lilly’s Alzheimer’s drug slows clinical decline in Phase II trial

January 11, 2021 Sales and Marketing Alzheimer's, Eli Lilly

Eli Lilly’s donanemab has shown significant slowing of decline in a composite measure of cognition and daily function in patients …
News

Roche’s influenza drug Xofluza gets EU approval

January 11, 2021 Sales and Marketing EC, Roche, influenza

The European Commission (EC) has approved Roche’s Xofluza (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 …
News

MaxCyte signs licensing deal with Myeloid Therapeutics

January 11, 2021 Sales and Marketing MaxCyte, Myeloid Therapeutics

MaxCyte, a global cell-based therapies and life sciences company, and Myeloid Therapeutics, a company harnessing and reprogramming myeloid cells to …
News
The Gateway to Local Adoption Series

Latest content

NanoSomiX and Beckman Coulter Diagnostics collaborate on blood tests for neurodegenerative diseases

July 30, 2026

EMA selects TrialAssure anonymisation platform for clinical trial documents

July 30, 2026

Researchers develop new antifungal compounds with improved safety profile

July 29, 2026

Lonza and Engitix partner to develop next-generation antibody-drug conjugates

July 28, 2026

Simris Group appoints Tiffany J Vora as Strategic Advisor

July 28, 2026